AIXTRON SE: Release according to Article 40 Section 1 of the ...
LEG Immobilien SE: Release according to Article 40 Section 1 ...
LEG Immobilien SE: Release according to Article 40 Section 1 ...
Evonik Industries AG: Release according to Article 40 Section ...
OPPO and Fashion Pioneer AMBUSH® Launch Exclusive New Accessory ...
TAG Immobilien AG: Release according to Article 40 Section 1 ...
Critical Infrastructure Still at High Risk: Forescout Research ...
Trade Republic receives full banking license from ECB.
Trade Republic receives full banking license from ECB.
Shelly Group AD reaffirms guidance for financial year 2023 following ...
Hello SDAX! SCHOTT Pharma reaches next milestone as a publicly ...
Siemens Energy AG: Release according to Article 40 Section 1 ...
Krones shares return to MDAX index
Leading Indian Banks Leverage FICO's Cloud Platform for Enhanced ...
Takeda and The New York Academy of Sciences Announce 2024 Innovators ...
FPT Acquires Majority Stake of French IT Consulting Firm AOSIS ...
Deutsche Börse admits Mutares to the SDAX
Evotec-partner Jingxin receives approval for EVT201 in China
ExaGrid Wins 2 Industry Awards at the SDC Awards 2023
Saudi Fund for Development Provides $100 Million Development ...
ReNAgade Therapeutics Appoints Paul Perreault to Board of Directors ...
AArete Joins Snowflake Partner Network
Mansion Entertainment Group in Position to Re-align the Worldwide ...
Update on current trading and mid-term guidance as part of Arbonia’s ...
Cosmo confirms full redemption in cash of €175m Convertible ...
New appointment to Carbios' Executive Committee to secure rapid ...
Merck Provides Update on Phase III Results for Evobrutinib in ...
CIOs and CTOs Across Australia and New Zealand Struggle Balancing ...
SMI Vantage Signs Bitcoin Mining Lease Agreement
Fujitsu optimizes installation of EV charging infrastructure ...
Pertamina NRE presents Indonesia's EV ecosystem at COP28
GMEX ZERO13 wins COP28 TechSprint and continues network expansion ...
Rural-fintech Startup Navadhan Raises USD 5M Led by Prime Venture ...
Merck KGaA: Phase III trial results for evobrutinib in relapsing ...